Biomerica, Inc. (BMRA)
2.24
-0.10
(-4.27%)
USD |
NASDAQ |
Sep 09, 16:00
2.24
0.00 (0.00%)
After-Hours: 17:10
Biomerica Enterprise Value : 8.552M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 8.552M |
| September 04, 2026 | 8.456M |
| September 03, 2026 | 8.169M |
| September 02, 2026 | 8.105M |
| September 01, 2026 | 7.753M |
| August 31, 2026 | 7.753M |
| August 28, 2026 | 7.913M |
| August 27, 2026 | 7.785M |
| August 26, 2026 | 6.475M |
| August 25, 2026 | 6.731M |
| August 24, 2026 | 6.443M |
| August 21, 2026 | 6.219M |
| August 20, 2026 | 6.140M |
| August 19, 2026 | 5.932M |
| August 18, 2026 | 6.188M |
| August 17, 2026 | 6.060M |
| August 14, 2026 | 6.124M |
| August 13, 2026 | 6.251M |
| August 12, 2026 | 6.092M |
| August 11, 2026 | 6.092M |
| August 10, 2026 | 6.283M |
| August 07, 2026 | 6.219M |
| August 06, 2026 | 6.188M |
| August 05, 2026 | 6.251M |
| August 04, 2026 | 5.964M |
| Date | Value |
|---|---|
| August 03, 2026 | 5.964M |
| July 31, 2026 | 5.836M |
| July 30, 2026 | 6.155M |
| July 29, 2026 | 6.156M |
| July 28, 2026 | 6.188M |
| July 27, 2026 | 6.252M |
| July 24, 2026 | 6.140M |
| July 23, 2026 | 6.188M |
| July 22, 2026 | 6.092M |
| July 21, 2026 | 6.321M |
| July 20, 2026 | 6.188M |
| July 17, 2026 | 6.232M |
| July 16, 2026 | 6.283M |
| July 15, 2026 | 6.395M |
| July 14, 2026 | 6.283M |
| July 13, 2026 | 6.475M |
| July 10, 2026 | 6.475M |
| July 09, 2026 | 6.347M |
| July 08, 2026 | 6.379M |
| July 07, 2026 | 6.563M |
| July 06, 2026 | 6.603M |
| July 02, 2026 | 6.667M |
| July 01, 2026 | 6.826M |
| June 30, 2026 | 6.699M |
| June 29, 2026 | 6.731M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 210.25B |
| Align Technology, Inc. | 9.954B |
| AngioDynamics, Inc. | 591.77M |
| Accuray, Inc. | 177.77M |
| Alphatec Holdings, Inc. | 1.912B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.145M |
| Revenue (Quarterly) | 0.875M |
| Total Expenses (Quarterly) | 2.02M |
| EPS Diluted (Quarterly) | -0.3729 |
| Gross Profit Margin (Quarterly) | -8.11% |
| Profit Margin (Quarterly) | -130.9% |
| Earnings Yield | -56.33% |
| Normalized Earnings Yield | -59.74 |